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ABSTRACT 
Objective: To determine the prevalence of major depressive disorder (MDD) in 
hematological cancer patients and to investigate MDD with quality of life. Methods: The 
research, which uses a cross sectional design, has been carried out at Ampang Hospital, 
Kuala Lumpur. The hospital is a tertiary referral center for cancer cases that include non-
Hodgkin lymphoma, acute myelogenous leukemia, acute lymphoblastic leukemia, Hodgkin 
lymphoma and other hematological cancers. In total, 105 patients with hematological 
malignancies were included in the study. This study employed the MINI International 
Neuropsychiatric Interview for diagnosis of MDD, the Patient Health Questionnaire (PHQ-9) 
for symptom severity of depression and the European Organisation for Research and 
Treatment of Cancer Quality Of Life questionnaire (EORTC QLQ-C30) to assess the quality 
of life of the respondents. Result: The response rate was 83.3%. The prevalence of MDD was 
24.8% (n=26) with the majority of cases classified as moderately severe depression (38.5%). 
About 92.3% (n=24) of depressed hematological cancer patients were diagnosed with a 
current episode of MDD. The depressed patients also had significantly reduced quality of life 
in physical, role, emotional, cognitive and social domains (p<0.05). They also had 
significantly more symptoms of fatigue, nausea and vomiting, dyspnea, insomnia, appetite 
loss, constipation and diarrhea in addition to having financial difficulties and poor global 
health statuses (p<0.05). Conclusion: The prevalence of depression among the hematological 
cancer patients was high and the depressed patients had reduced qualities of life. Special 
attention in psychotherapy would help to improve both depression level and the quality of life 
in these patients. 
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